Caprelsa (Vandetanib)

Caprelsa (Vandetanib)

Brand Name : Caprelsa
Composition : Vandetanib 300mg
Manufactured by : Sanofi Genzyme
Form : Tablet
Packing : Pack of 30 Tablets

Category:

Caprelsa (vandetanib) is indicated for the treatment of aggressive and symptomatic medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease.

This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.